U.S. stocks have pulled back from record highs as the Federal Reserve commenced its September policy meeting. This pause in stock market momentum comes amid heightened anticipation regarding the central bank’s upcoming decisions on interest rates and monetary policy.
In an interesting turn of events, gold has surged to a historic high, exceeding $3,700 an ounce for the first time. This spike reflects investor sentiment and is often viewed as a safe haven during times of economic uncertainty.
On the corporate front, shares of Rocket Lab are experiencing a downturn following the announcement of a new $750 million at-the-market equity offering. This strategy allows the space exploration company to gradually sell shares through various investment banks, which has raised concerns among investors. This news follows their earlier sale of $396.6 million worth of shares under a previous agreement, indicating a more aggressive approach to capital raising.
Additionally, shares of Hims and Hers Health are facing downward pressure after the company received a warning letter from the Food and Drug Administration (FDA). The letter states that the company’s claims regarding compounded semiglutide products listed on their website are false or misleading, labeling the products as misbranded drugs. This regulatory scrutiny is likely to impact investor confidence and may lead to further complications for the company moving forward.
For those tracking market performance, more information and updates on the best and worst performing stocks of the session are available on Yahoo Finance.
